A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/03/2011	CN102138919A New application of sodium ferrous chlorophyll to promotion of erythropoiesis
08/03/2011	CN102138918A Application of kaempferol in the preparation of medicines for preventing and/or treating cardiovascular diseases
08/03/2011	CN102138917A Application of dimethyl xanthocillin to preparation of antitubercular medicaments
08/03/2011	CN102138916A Levo-gossypol for treating tumors or cyclodextrin clathrate compound of acetate thereof
08/03/2011	CN102138913A Ranitidine hydrochloride capsules and production method thereof
08/03/2011	CN102138912A Nifedipine osmotic pump controlled release tablet and preparation method thereof
08/03/2011	CN102138911A Divalproex sodium sustained release tablets and preparation method thereof
08/03/2011	CN102138910A Atorvastatin calcium tablets and preparation method thereof
08/03/2011	CN102138907A Stable rabeprazole sodium freeze-dried preparation and preparation method thereof
08/03/2011	CN102138906A Clonidine hydrochloride sustained release micropill preparation
08/03/2011	CN102138903A Everolimus solid oral medicinal composition
08/03/2011	CN102138902A Inhalation composition
08/03/2011	CN102138901A Nasal spray or aerosol containing Fasudil
08/03/2011	CN102138900A Solid preparation of oxapium iodide liposome
08/03/2011	CN102138899A Olmesartan liposome solid preparation
08/03/2011	CN102138898A Nanometer liposome serving as antitumor medicament
08/03/2011	CN102138897A Composition preparation of lomefloxacin compound and sodium chloride and preparation method thereof
08/03/2011	CN102138896A Clofarabine injection and preparation method thereof
08/03/2011	CN102138895A Eyedrops containing fasudil hydrochloride and preparation method thereof
08/03/2011	CN102138894A Stable large-capacity fasudil hydrochloride injection
08/03/2011	CN102138893A Preparation process and use of sodium lysinrofen chloride injection
08/03/2011	CN102138892A Choline alfoscerate injection preparation as well as preparation method and detection method thereof
08/03/2011	CN102138891A Ketorolac tromethamine injection
08/03/2011	CN102138890A Praziquantel transdermal preparation and applications thereof
08/03/2011	CN102138889A Targeted drug-bearing ultrasonic microbubble and preparation method thereof
08/03/2011	CN102138888A Alprostadil lipid nanosphere gel and preparation method thereof
08/03/2011	CN102138886A Preparation for socks capable of eliminating foot smell and preventing dermatophytosis
08/03/2011	CN101919837B Application of rosmarinic acid in preparing medicament for treating or preventing renal fibrosis
08/03/2011	CN101890110B White tiger sesame oil scalding ointment and preparation method thereof
08/03/2011	CN101889973B Itraconazole gel for dogs and preparation method thereof
08/03/2011	CN101816666B Use of forsythiaside as synergist of antifungal agents
08/03/2011	CN101816646B Application of theaflavin as synergist of antifungal medicine
08/03/2011	CN101797304B Gel for adjusting microecology in vaginas of women
08/03/2011	CN101797266B Pharmaceutical composition containing quercetin and usage thereof
08/03/2011	CN101791378B Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration
08/03/2011	CN101787000B M-stage kinesin inhibitor
08/03/2011	CN101780090B Tablet containing valsartan and hydrochlorothiazide
08/03/2011	CN101766706B Medicinal combination containing borneol and musk
08/03/2011	CN101766705B Medicinal combination containing borneol and musk
08/03/2011	CN101766704B Medicinal combination containing borneol and musk
08/03/2011	CN101766703B Medicinal combination containing borneol and musk
08/03/2011	CN101766702B Medicinal combination containing borneol and musk
08/03/2011	CN101766701B Medicinal combination containing musk
08/03/2011	CN101766700B Medicinal combination containing musk
08/03/2011	CN101766699B Medicinal combination containing musk
08/03/2011	CN101732457B External traditional Chinese medicine composition
08/03/2011	CN101732229B Borneol inclusion compound and preparation method thereof
08/03/2011	CN101716214B Medical composition containing dandelion extract as well as novel application and preparation method thereof
08/03/2011	CN101716134B 2-methoxyestradiol transdermal liniment and 2-methoxyestradiol transdermal patch
08/03/2011	CN101690820B Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof
08/03/2011	CN101683468B Medicament for treating burns and scalds and preparation method thereof
08/03/2011	CN101664476B Medicinal pillow
08/03/2011	CN101642521B Medicine for treating cerebral apoplexy hemiplegy sequela
08/03/2011	CN101627997B 3-amino-1-nitro-guanyl-2-piperidones and application of salts thereof in preparation of medicines for treating cardiovascular diseases
08/03/2011	CN101618019B Triamcinolone acetonide acetate particle, and preparation method and medicinal composition thereof
08/03/2011	CN101606985B Liniment for treating sheep infective pustule virus and preparation method thereof
08/03/2011	CN101591285B Propionamides compound and usage thereof
08/03/2011	CN101590077B Compound erythromycin zinc acetate ointment for local use
08/03/2011	CN101580554B Anoectochilus roxburghii polyose, applications thereof in pharmacy and preparation method of anoectochilus roxburghii polyose
08/03/2011	CN101580507B Novel antitumor compound and preparation method and application thereof
08/03/2011	CN101574327B Encapsulated agglomeration of microcapsules and method for the preparation thereof
08/03/2011	CN101573099B Cooling agent composition and preparative method thereof
08/03/2011	CN101548983B Skin disinfectant and method of producing the same
08/03/2011	CN101541776B Ascorbic acid derivates, their preparation methods, intermediates and uses in cosmetics
08/03/2011	CN101514222B Steroidal compound in Bugula neritina L. and use thereof
08/03/2011	CN101511793B Antitumor agent for undifferentiated gastric cancer
08/03/2011	CN101496798B Use of salvianolic acid B
08/03/2011	CN101461850B Application of Chinese medicinal composition in preparing medicament for treating acne
08/03/2011	CN101431990B Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol
08/03/2011	CN101411742B Capsule for freeing collateral vessels containing astragalus and leech
08/03/2011	CN101410381B Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs)
08/03/2011	CN101380316B Multifunctional external antibiotic preparation and production method thereof
08/03/2011	CN101379066B HCV NS5B inhibitors
08/03/2011	CN101361737B Use of 4-tetrahydrothiazole dione derivates
08/03/2011	CN101316590B Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
08/03/2011	CN101300251B Benzimidazole thiophene compounds as PLK inhibitor
08/03/2011	CN101273043B Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
08/03/2011	CN101270163B Single-chain fragment antibody-polypeptide amalgamation protein and uses thereof
08/03/2011	CN101253180B 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
08/03/2011	CN101213198B 1-[2',3'-dideoxy-3'C-(hydroxymethyl)-beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors
08/03/2011	CN101184756B Isoflavonoid dimers
08/03/2011	CN101176739B Toadpoison ligand extract as well as preparation method and application thereof
08/03/2011	CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
08/03/2011	CN101143861B B ring 4'-single substituted flavone compounds, preparation method and use
08/03/2011	CN101120959B Application of guhong injection for treating lung cancer
08/03/2011	CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
08/03/2011	CN101065360B Thermodynamically stable form of BAY 43-9006 tosylate
08/03/2011	CN101039680B Improved process for the preparation of oxidized phospholipids
08/02/2011	US7989661 Human ADAM-10 inhibitors
08/02/2011	US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders
08/02/2011	US7989655 reacting hydrogen sulfide with vegetable oils, in the presence of catalysts, to form mercaptanized vegetable oils; chemical intermediates for polythiourethanes used in fertilizers coatings
08/02/2011	US7989654 High purity bases of 3,3-diphenylpropylamino monoesters
08/02/2011	US7989652 C-nitroso-derived nitroxyl donors
08/02/2011	US7989650 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
08/02/2011	US7989640 Sulfonylpyrrolidine modulators of androgen receptor function and method
08/02/2011	US7989630 Radiotracers for imaging P-glycoprotein function
08/02/2011	US7989629 3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
08/02/2011	US7989626 Modulators of cellular adhesion
08/02/2011	US7989625 Thienopyridines
08/02/2011	US7989624 Aryl spirolactam CGRP receptor antagonists

1 ... 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 ... 7860